832 related articles for article (PubMed ID: 16377667)
21. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms.
Singh R; Ray P; Das A; Sharma M
J Antimicrob Chemother; 2010 Sep; 65(9):1955-8. PubMed ID: 20615927
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Staphylococcus epidermidis isolated from prosthetic joint infections and commensal isolates in regard to antibiotic susceptibility, agr type, biofilm production, and epidemiology.
Hellmark B; Söderquist B; Unemo M; Nilsdotter-Augustinsson Å
Int J Med Microbiol; 2013 Jan; 303(1):32-9. PubMed ID: 23245829
[TBL] [Abstract][Full Text] [Related]
23. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
[TBL] [Abstract][Full Text] [Related]
24. Staphylococcus epidermidis biofilms control by N-acetylcysteine and rifampicin.
Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R
Am J Ther; 2013; 20(4):322-8. PubMed ID: 21519220
[TBL] [Abstract][Full Text] [Related]
25. In vitro anti-biofilm activity of a biphasic gentamicin-loaded calcium sulfate/hydroxyapatite bone graft substitute.
Butini ME; Cabric S; Trampuz A; Di Luca M
Colloids Surf B Biointerfaces; 2018 Jan; 161():252-260. PubMed ID: 29096369
[TBL] [Abstract][Full Text] [Related]
26. The differential activity of aminoglycoside antibiotics with rifampin explored in a kinetic in vitro model of implant-associated infection (Staphylococcus epidermidis).
Richards GK; Morcos RJ; Gagnon RF
Adv Perit Dial; 1994; 10():183-8. PubMed ID: 7999823
[TBL] [Abstract][Full Text] [Related]
27. Antistaphylococcal activity of teicoplanin in Riyadh, Saudi Arabia.
Shibl AM; Ishag AH; Durgham SM
APMIS Suppl; 1988; 3():68-70. PubMed ID: 2972301
[TBL] [Abstract][Full Text] [Related]
28. Telavancin: in vitro activity against staphylococci in a biofilm model.
Gander S; Kinnaird A; Finch R
J Antimicrob Chemother; 2005 Aug; 56(2):337-43. PubMed ID: 15972312
[TBL] [Abstract][Full Text] [Related]
29. In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar.
Randrianirina F; Soares JL; Ratsima E; Carod JF; Combe P; Grosjean P; Richard V; Talarmin A
Ann Clin Microbiol Antimicrob; 2007 May; 6():5. PubMed ID: 17521424
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo antibiofilm activity of a coral associated actinomycete against drug resistant Staphylococcus aureus biofilms.
Bakkiyaraj D; Pandian SK
Biofouling; 2010 Aug; 26(6):711-7. PubMed ID: 20706890
[TBL] [Abstract][Full Text] [Related]
31. Activities of Combinations of Antistaphylococcal Antibiotics with Fusidic Acid against Staphylococcal Biofilms in
Siala W; Rodriguez-Villalobos H; Fernandes P; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712650
[TBL] [Abstract][Full Text] [Related]
32. Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure.
Manasherob R; Mooney JA; Lowenberg DW; Bollyky PL; Amanatullah DF
Clin Orthop Relat Res; 2021 Jul; 479(7):1471-1481. PubMed ID: 33835090
[TBL] [Abstract][Full Text] [Related]
33. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobials as potential adjunctive agents in the treatment of biofilm infection with Staphylococcus epidermidis.
Peck KR; Kim SW; Jung SI; Kim YS; Oh WS; Lee JY; Jin JH; Kim S; Song JH; Kobayashi H
Chemotherapy; 2003 Jul; 49(4):189-93. PubMed ID: 12886054
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
[TBL] [Abstract][Full Text] [Related]
36.
Delpech G; Ceci M; Lissarrague S; García Allende L; Baldaccini B; Sparo M
Biofouling; 2020 Mar; 36(3):266-275. PubMed ID: 32338055
[No Abstract] [Full Text] [Related]
37. Comparative assessment of antimicrobial activities of antibiotic-treated penile prostheses.
Mansouri MD; Boone TB; Darouiche RO
Eur Urol; 2009 Dec; 56(6):1039-45. PubMed ID: 19135292
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of a new antibacterial rhodanine derivative against Staphylococcus epidermidis biofilms.
Gualtieri M; Bastide L; Villain-Guillot P; Michaux-Charachon S; Latouche J; Leonetti JP
J Antimicrob Chemother; 2006 Oct; 58(4):778-83. PubMed ID: 16880176
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001.
Kresken M; Hafner D; Schmitz FJ; Wichelhaus TA;
Int J Antimicrob Agents; 2004 Jun; 23(6):577-81. PubMed ID: 15194128
[TBL] [Abstract][Full Text] [Related]
40. Tigecycline inhibition of a mature biofilm in clinical isolates of Staphylococcus aureus : comparison with other drugs.
Cafiso V; Bertuccio T; Spina D; Purrello S; Stefani S
FEMS Immunol Med Microbiol; 2010 Aug; 59(3):466-9. PubMed ID: 20528931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
